Having trouble accessing articles? Reset your cache.

Medicines Co. gains on Angiomax decision

The Medicines Co. (NASDAQ:MDCO) gained $3.14 (34%) to $12.47 on Tuesday after a district court ordered the U.S.

Read the full 180 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE